Innospec

IOSP · NYSE · Materials · United States

Financials at a glance

Source: SEC XBRL

Annual

FY2023FY2024FY2025$1.9B$1.9B$1.8B$1.8B$1.8B$1.8B6.6% margin6.6% marginRevenueNet margin

Quarterly · last 8

Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26$500.2M$500.2M$435.0M$435.0M$443.4M$443.4M$440.8M$440.8M$439.7M$439.7M$441.9M$441.9M$453.2M$453.2M$491.4M$491.4M6.3% margin6.3% marginRevenueNet margin

Revenue (FY2025)

$1.8B

Net margin

6.6%

ROE

8.8%

Revenue CAGR (2y)

-4.5%

Profit CAGR (2y)

-8.4%

EPS (FY2025)

4.67

Net profit (FY2025)

$116.6M

Ask MarketChacha about IOSP

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

PeriodRevenueNet profitEPSNet marginROE
FY2025$1.8B$116.6M4.676.6%8.8%
FY2024$1.8B$35.6M1.421.9%2.9%
FY2023$1.9B$139.1M5.567.1%12.1%

Quarterly

PeriodRevenueNet profitEPSNet margin
2026Q2$491.4M$30.8M1.256.3%
2026Q1$453.2M$30.4M1.226.7%
2025Q3$441.9M$12.9M0.522.9%
2025Q2$439.7M$23.5M0.945.3%
2025Q1$440.8M$32.8M1.317.4%
2024Q3$443.4M$33.4M1.337.5%
2024Q2$435.0M$31.2M1.247.2%
2024Q1$500.2M$41.4M1.658.3%
2023Q3$464.1M$39.2M1.578.4%
2023Q2$480.4M$28.9M1.166.0%
2023Q1$509.6M$33.2M1.336.5%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.